Vertex’s $320 Million Acquisition of ViaCyte

Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte.Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire ViaCyte,…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now